PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New drug prospect offers hope against hookworm infections

Study at UCSF and Yale finds protease inhibitors are potent, single-day cures for disease in hamsters

2012-07-04
(Press-News.org) A drug candidate that is nearing clinical trials against a Latin American parasite is showing additional promise as a cure for hookworm, one of the most widespread and insidious parasites afflicting developing nations, according to a collaborative study at UCSF and Yale University.

The drug candidate, known by the scientific name K11777, is under development at UCSF and is targeted to enter clinical trials in the next one to two years to treat Chagas disease, a potentially fatal parasitic disease common to Latin America.

In the current study, researchers at the UCSF Center for Discovery and Innovation in Parasitic Diseases and the Yale University School of Medicine tested K11777 both in culture and in hamsters against the parasite Ancylostoma ceylanicum, one of several species of hookworm that afflict as many as 1.2 billion people worldwide.

The compound, which works by inhibiting cysteine proteases – key enzymes in the parasite's gut that help digest its blood meal – proved more than 90 percent effective in a single oral dose and completely cured hamsters of hookworm in two doses, according to a paper being published July 3, 2012 in the Public Library of Science (PLoS) Neglected Tropical Diseases.

The studies are the first step in assessing whether this class of drugs could be effective against hookworm in humans, either alone or in combination with current therapies, according to senior author Conor Caffrey, PhD, a senior scientist at the UCSF center and researcher in the UCSF Department of Pathology.

"The harbinger of concern is that for worm parasites of cattle and sheep, there is rampant resistance to the same or similar drugs that are currently being used to treat humans," Caffrey said. "Up to now, these have performed reasonably well but we're starting to hear reports of lower effectiveness, so we're working hard to identify new drug candidates before the inevitable happens."

Among parasitic diseases, hookworm infection is second only to malaria as a cause of disability worldwide. While not usually fatal, the infection is debilitating, slowing children's development and causing or exacerbating iron-deficiency anemia, which can be serious in young children and pregnant women, especially in those who already are undernourished.

Hookworm spreads when larvae from human waste penetrate human skin via moist soil, most commonly in underdeveloped areas where children go barefoot.

Among the surprises in the study was the potency of the compound against these worms. After starting with multiple doses, the team steadily cut back until they realized they had 90 percent effectiveness in one dose.

Because the current drugs, mebendazole and albendazole, are generally given as a single oral dose to treat the infection in humans, this level of potency was exactly what the researchers needed to consider it as a possibility for humans, Caffrey said.

If it proves safe and effective in humans, that single-dose therapy could be a potent new tool in the arsenal against hookworm and other worm parasites, providing a new solution that could be delivered using distribution systems already in place in under-developed conditions, according to the paper.

Even if K11777 does not end up as a new therapy, the discovery opens the door to developing cysteine protease inhibitors as a new class of drugs to treat hookworm and, perhaps, other intestinal nematode infections, Caffrey said. This also could have ramifications for treating similar parasites in the animal health industry.

### The research and paper were jointly performed by Caffrey and two other researchers: Jon J. Vermeire, PhD, and Lorine D. Lantz of the Department of Pediatrics, Section of Infectious Diseases, at Yale University School of Medicine.

The research was supported by the Sandler Foundation, the Yale Child Health Research Center and by the NIH grant K22A09476. The researchers declare no competing interests in the research.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. Visit www.ucsf.edu.

Follow UCSF UCSF.edu | Facebook.com/ucsf | Twitter.com/ucsf | YouTube.com/ucsf

Additional links: http://www.ucsf.edu/news/2009/07/8191/parasite-gene-map-schistosome-flatworm-genome-spurs-protease-inhibitor-sear

END



ELSE PRESS RELEASES FROM THIS DATE:

Shrinking leaves point to climate change

2012-07-04
University of Adelaide researchers have discovered that recent climate change is causing leaves of some Australian plants to narrow in size. The study, which is the first of its kind in the world, highlights that plant species are already responding to changes in climate. The results are published online today in the Royal Society journal Biology Letters. Researchers analysed leaves from herbarium specimens of Narrow-leaf Hopbush (Dodonaea viscosa subsp. angustissima) dating from the 1880s to the present. The study focused on specimens from South Australia's Flinders ...

Researchers develop an artificial cerebellum than enables robotic human-like object handling

2012-07-04
University of Granada researchers have developed an artificial cerebellum (a biologically-inspired adaptive microcircuit) that controls a robotic arm with human-like precision. The cerebellum is the part of the human brain that controls the locomotor system and coordinates body movements. To date, although robot designers have achieved very precise movements, such movements are performed at very high speed, require strong forces and are power consuming. This approach cannot be applied to robots that interact with humans, as a malfunction might be potentially dangerous. To ...

A study demonstrates that ibuprofen improves bone repair after surgery or a fracture

2012-07-04
A study conducted at the University of Granada hasdemonstrated that ibuprofen ­–a non-steroidal anti-inflammatory drug (NSAID)­– has beneficial effects on bone repair after afracture or following bone surgery. In vitro tests demonstrated that –unlike other NSAIDs– when a therapeutic dose of ibuprofen is administered, it has no negative effects on the proliferation and synthesis of obsteoblast osteocalcin, a cell which is directly involved in the formation and regeneration of bones. Osteoblast cells are bone cells that synthesize the bone matrix. Consequently, osteoblasts ...

What's cooking? The UK's potential food crisis

2012-07-04
The Sustainable Consumption Institute research claims food which families now take for granted, such as meat and fresh vegetables, could become too expensive for many if global temperatures rise in line with the current trends and reach 4°C within the lifetime of many people. Even if families continue to take steps to lower their carbon emissions from energy use, global farming emissions will continue to rise because of our growing appetite for energy-intensive foods and a rising demand to meet just basic living standards across the world. Only by reducing consumption ...

The big sleep

2012-07-04
All zoo animals – and sometimes also wild animals – occasionally need veterinary treatment and anaesthesia is clearly required in many cases. For most animals the procedures are well established but for a variety of reasons it has proven difficulty to anaesthetize hippopotamuses. The thick skin and the dense subcutaneous tissue make it difficult to introduce sufficient amounts of anaesthetics and opioid-based anaesthetics often cause breathing irregularities and occasionally even death. In addition, the level of anaesthesia is only rarely sufficient to enable surgery to ...

Searching for an ancient syphilis DNA in newborns

2012-07-04
The ancient bones of newborns are very useful to recover the ancient DNA of the bacteria causing syphilis, the Treponema pallidum pallidum. This is the conclusion reached by a study led by Universitat Autònoma de Barcelona (UAB), which was able to obtain the genetic material from the bacteria in more than one individual, in what is considered to be the oldest case known to date. Several previous intents had only achieved to yield this material in one occasion and from only one individual. Studying syphilis represents a challenge for researchers, in part because of the ...

Rising plasma offers clues to sun storms

2012-07-04
Doppler measurements that help track storms on Earth may also be useful for understanding storms on the sun. A Rice University astrophysicist is part of an international team that combined Doppler techniques with images and data from a space-based telescope to observe, for the first time, loops of 1,800,000-degree Fahrenheit plasma flowing up from the sun's surface at more than 12 miles per second. The loops, rooted in active regions near sunspots and guided by the sun's magnetic field, arch over the sun and may be the first signs of trouble spots, where plasma undergoes ...

Feathered saurians -- downy dinosaur discovered

2012-07-04
The new fossil find from the chalk beds of the Franconian Jura evokes associations with a pet cemetery, for the young predatory dinosaur reveals clear traces of fluffy plumage. It also poses an intriguing question: Were all dinosaurs dressed in down? The fossil of the fledgling saurian, probably newly hatched when it met its end, is remarkable in many ways. First of all, juveniles are extremely rare in the dinosaur fossil record, so every new discovery provides insights into dinosaur nurseries. Moreover, this specimen is perhaps the best-preserved predatory dinosaur that ...

Toward an alternative for antibiotics to fight bacterial infections?

2012-07-04
VIB researcher Mohamed Lamkanfi, connected to the Ghent University, discovered that mice that do not produce the receptor protein NLRP6, are better protected against bacterial infections and can easier remove bacteria from the body. Therapeutic drugs that neutralize NLRP6 could be a possible treatment option, in addition to the use of antibiotics, for fighting bacterial infections. His research was published in the leading scientific magazine Nature. Mohamed Lamkanfi (VIB – Ghent University): "Our lab investigates the role of the innate immunity, which is of crucial importance ...

Parents less likely to develop colds, Carnegie Mellon research shows

2012-07-04
PITTSBURGH—There is no question that being a parent is, at times, challenging both physically and mentally. However knowledge of the actual affect parenthood has on health has been inconsistent at best, until now. New research led by Carnegie Mellon University's Sheldon Cohen and Rodlescia S. Sneed shows that being a parent influences health in a positive way. Published in Psychosomatic Medicine, the research provides the first evidence that, when exposed to a common cold virus, parents are 52 percent less likely to develop a cold than non-parents. "We have had a long-term ...

LAST 30 PRESS RELEASES:

Study offers new hope for relieving chronic pain in dialysis patients

How does the atmosphere affect ocean weather?

Robots get smarter to work in sewers

Speech Accessibility Project data leads to recognition improvements on Microsoft Azure

Tigers in the neighborhood: How India makes room for both tigers and people

Grove School’s Arthur Paul Pedersen publishes critical essay on scientific measurement literacy

Moffitt study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer

Improving blood transfusion monitoring in critical care patients: Insights from diffuse optics

Powerful legal and financial services enable kleptocracy, research shows

Carbon capture from constructed wetlands declines as they age

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

Life cycles of some insects adapt well to a changing climate. Others, not so much.

With generative AI, MIT chemists quickly calculate 3D genomic structures

The gut-brain connection in Alzheimer’s unveiled with X-rays

NIH-funded clinical trial will evaluate new dengue therapeutic

Sound is a primary issue in the lives of skateboarders, study shows

Watch what you eat: NFL game advertisements promote foods high in fat, sodium

Red Dress Collection Concert hosted by Sharon Stone kicks off American Heart Month

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

New Case Western Reserve University study identifies key protein’s role in psoriasis

First-ever ethics checklist for portable MRI brain researchers

Addressing 3D effects of clouds for significant improvements of climate models

Gut microbes may mediate the link between drinking sugary beverages and diabetes risk

Ribosomes team up in difficult situations, new technology shows

Mortality trends among adults ages 25-44 in the US

Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among us adults with overweight or obesity

Ultraprocessed food consumption and obesity development in Canadian children

Experts publish framework for global adoption of digital health in medical education

Canadian preschoolers get nearly half of daily calories from ultra-processed foods: University of Toronto study

[Press-News.org] New drug prospect offers hope against hookworm infections
Study at UCSF and Yale finds protease inhibitors are potent, single-day cures for disease in hamsters